Immunotherapies for sepsis and the impact of study design

Authors

John H. Powers, Director of Collaborative Research, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA john.powers@nih.gov.
Charles Natanson, Critical Care Medicine Branch, National Heart, Lung, and Blood Institute and Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD, USA.

Document Type

Editorial

Publication Date

1-15-2025

Journal

BMJ (Clinical research ed.)

Volume

388

DOI

10.1136/bmj.r48

APA Citation

Powers, John H. and Natanson, Charles, "Immunotherapies for sepsis and the impact of study design" (2025). GW Authored Works. Paper 6357.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6357

Department

Medicine